Cargando…
A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia
INTRODUCTION: Fibromyalgia is a chronic disorder characterized by widespread pain and tenderness. Prior trials have demonstrated the efficacy of pregabalin for the relief of fibromyalgia symptoms, and it is approved for the treatment of fibromyalgia in the United States. However, prior to this study...
Autores principales: | Ohta, Hiroyoshi, Oka, Hiroshi, Usui, Chie, Ohkura, Masayuki, Suzuki, Makoto, Nishioka, Kusuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580529/ https://www.ncbi.nlm.nih.gov/pubmed/23062189 http://dx.doi.org/10.1186/ar4056 |
Ejemplares similares
-
A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients
por: Murakami, Masato, et al.
Publicado: (2015) -
Brain perfusion in fibromyalgia patients and its differences between responders and poor responders to gabapentin
por: Usui, Chie, et al.
Publicado: (2012) -
Research platform for fibromyalgia in Japan
por: Nishioka, Kusuki
Publicado: (2012) -
Brain perfusion in fibromyalgia patients and its differences between responders and poor responders to gabapentin
por: Usui, Chie, et al.
Publicado: (2010) -
Pregabalin in Treatment-Refractory Fibromyalgia
por: Stacey, Brett R, et al.
Publicado: (2010)